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Abstract
Pericardial fat (PF) a component of visceral adipose tissue has been consistently
related to coronary atherosclerosis in the general population. This study evaluated
the association between PF and coronary artery calcification (CAC) in non-dialysis
dependent chronic kidney disease (CKD) patients. This is a post-hoc cross
sectional analysis of the baseline of a prospective cohort of 117 outward CKD
patients without manifest coronary artery disease (age, 56.9¡11.0 years, 64.1%
males, 95.1% hypertensives, 25.2% diabetics, 15.5% ever smokers, CKD stage 2
to 5 with estimated glomerular filtration rate 36.8¡18.1 ml/min). CAC scores, PF
volume and abdominal visceral fat (AVF) areas were measured by computed
tomography. The association of PF as a continuous variable with the presence of
CAC was analyzed by multivariate logistic regression. CAC (calcium score.0) was
present in 59.2% patients. Those presenting CAC were on average 10 years older,
had a higher proportion of male gender (78.7% vs. 42.9%, p,0.001), and had
higher values of waist circumference (95.9¡10.7 vs. 90.2¡13.2 cm, p50.02), PF
volumes (224.8¡107.6 vs. 139.1¡85.0 cm3, p,0.01) and AVF areas
(109.2¡81.5 vs. 70.2¡62.9 cm2, p50.01). In the multivariate analysis, adjusting
for age, gender, diabetes, smoking and, left ventricular concentric hypertrophy, PF
was significantly associated with the presence of CAC (OR: 1.88 95% CI: 1.03–
3.43 per standard deviation). PF remained associated with CAC even with
additional adjustments for estimated glomerular filtration rate or serum phosphorus
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(OR: 1.85 95% CI: 1.00–3.42, p50.05). PF is independently associated with CAC in
non-dialysis dependent CKD patients.
Introduction
Chronic kidney disease (CKD) is highly prevalent affecting roughly 7% of the
general adult population and up to one in three elder individuals [1]. Despite
concerns about progression of CKD from stages 1–3 to stages 4 and 5, overall
mortality risk overrides the risk of end stage renal disease onset by a 20-time
factor [2]. Indeed cardiovascular mortality is responsible for 50% of overall deaths
and is up to 20 times more incident in CKD individuals than in the general
population [3].
Coronary artery calcification (CAC), a marker of subclinical vascular disease
that is highly prevalent in CKD, reliably predicts the risk for overall mortality and
cardiovascular events in dialytic [4, 5] as well as in non-dialytic patients [6, 7]. The
mechanisms of CAC buildup in CKD patients are multiple, and classic
atherosclerotic risk factors like hypertension and dyslipidemia interact with
factors related with uremia like malnutrition, inflammation [8], and disorders of
mineral metabolism [9].
Pericardial fat (PF) comprises all fatty tissues in the mediastinum surrounding
the myocardium, especially over the epicardial coronary track [11]. As a
component of the visceral fat compartment, PF produces highly active cytokines
[10]. Since there is no physical barrier between PF and coronary arteries, PF has
been advocated as a paracrine promoter of CAC. This hypothesis is supported by
studies in non-CKD populations associating PF respectively with CAC presence
[11, 12], high-risk coronary atherosclerotic plaque features [13] and incident
myocardial infarction [14]. PF has been related with coronary plaque presence
even in lean individuals [15], which support the hypothesis that PF could reflect
more accurately a riskier adiposity in comparison with other fatness parameters.
There is limited evidence associating epicardial and pericardial fat with CAC in
CKD individuals [16, 17]. The aim of this study was to test the association of PF
with CAC presence both measured by computed tomography in non-dialysis
dependent CKD patients.
Material and Methods
Patients
This is a post hoc analysis from a prospective cohort that comprised 117 stage 2–5
non-dialysis chronic kidney disease (ND CKD) patients followed at the outpatient
clinic of the Nephrology Division, Federal University of Sa˜o Paulo (UNIFESP) in
Sao Paulo, Brazil [6]. All patients had been previously submitted to cardiac
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computed tomography for CAC quantification, but just 103 had adequate images
for PF reading. This study was approved by UNIFESP9s institutional review board
and a written informed consent was obtained from all participants.
The exclusion criteria were: age ,18 years, presence of chronic inflammatory
diseases, current malignancy, HIV infection, viral hepatitis, chronic steroid usage,
and previous manifestations of coronary heart disease. The majority was using
angiotensin converting enzyme inhibitors (82.2%); 22.9% angiotensin receptor
blockers, 77.1% diuretics, 41.5% beta-blockers, 34% patients were on statins and
4.2% on recombinant human erythropoietin. Thirty patients (29.1%) were using
sevelamer, six (5.0%) calcium based phosphate binders, and six (5.0%) calcitriol.
Clinical, Laboratory and Echocardiography Evaluation
All patients underwent clinical evaluation, where their personal and familiar
previous medical history and physical exam were addressed. Diabetes was defined
as a fasting glucose .126 mg/dL or current usage of any anti-diabetic medication.
Hypertension was ascertained by average blood pressure over 140690 mmHg in
two subsequent measurements after 15 minutes resting in sitting position or usage
of any anti-hypertensive medication. Current smoking was defined as any
cigarette consumption in the last month and ever smoking as any previous daily
cigarette sustained consumption for at least 6 months. Body weight (kg), height
(m), waist circumference (cm), as well as systolic and diastolic arterial pressure
(mmHg) were measured as previously described [6]. The body mass index (kg/
m2) was calculated. Blood samples were drawn in the fasting state. The
biochemical parameters including serum creatinine, ionic calcium, phosphorus,
alkaline phosphatase, lipid profile, hemoglobin, albumin and intact parathyroid
hormone (iPTH) were measured by chemiluminescence immunoassay (Immulite;
DPC-Biermann, Bad Nauheim, Germany). High-sensitivity C-reactive protein
(CRP) was measured by an immunometric assay (Immunolite, Immunometric
Assay, CA, USA). Proteinuria was directly measured by 24-hour urine samples
and the glomerular filtration rate (eGFR) was estimated by the simplified
‘‘Modification of Diet in Renal Disease’’ (MDRD) equation. Abnormal
proteinuria was defined as excretion .300 mg/24 hours. The diagnosis and
classification of CKD was determined according to KDIGO guidelines criteria
[18].
A two-dimensional color Doppler echocardiogram was performed in each
patient according to the recommendations of the American Society of
Echocardiography [19] using the Philips HDI 5000 equipment (Royal Philips
Electronics, Netherlands). Left ventricular concentric hypertrophy was defined as
the presence of left ventricular mass hypertrophy and abnormal concentric
remodeling. Relative wall thickness .0.42 was considered abnormal and a left
ventricular mass index .115 g/m2 and .95 g/m2 respectively in men and women
was considered elevated [20]. Left ventricular dysfunction was defined by an
ejection fraction #55%.
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Coronary Artery Calcification Evaluation
CAC was quantified by multi-slice computed tomography (LightSpeed Pro 16; GE
Healthcare, Milwaukee, WI). The tomographic axial slices were acquired with a
2.5 mm thickness, prospective acquisition and synchronization to EKG, with a 0.4
seconds rotation, temporal reconstruction by 6 frames per second, and W-ray
tube voltage of 120 kV and 350 mA. CAC was quantified as previously described
by Agatston et al. [21]. Any CAC.0 was categorized as CAC presence. CAC
severity was stratified in: 0;.0–100 and .100 Agatston Units (AU).
Pericardial Fat, Visceral and Subcutaneous Abdominal Fat
Quantifications
The PF was analyzed at the Lipid Clinic of the Heart Institute (InCor) University
of Sao Paulo Medical School Hospital (HCFMUSP) with supervision from the
Cardiac Tomography and Resonance Service at the same hospital. The images
obtained for CAC measurement were recovered and uploaded on an I- Mac Apple
computer with and Intel Core i3 processor running MacOSx version 10.6. The
Osirix Imaging Software (Pixmeo, Switzerland), open source version 3.9 [22] was
used for fat quantification by a semi-automatic process developed at InCor. The
PF volume (in cm3) was calculated from measurements of each PF axial slice area
(in cm2). In each tomography slice a semi-automatic selection by radiodensity
window ranging from 230 to 2200 Hounsfield units using the limiar technique
(threshold) was made. For the segmentation, a tool from the Osirix software,
which detects tissues within the mentioned thresholds surrounding the selection
point was used. By this technique fat areas demarked in each axial slice, and fat
outside PF borders were manually delimitated to display the final axial area (
Figure 1). The PF boundaries were defined as: 1-superior, pericardial reflexion
near the pulmonary artery and bellow aortic arch; 2-inferior, diaphragmatic
transition; 3-posterior the line between the right and left main bronchi; and 4-
anterior, the internal limit of anterior thoracic wall. The PF volume was then
obtained by the sum of each axial slice area weighted by its own thickness, from
the diaphragm up to the last slice registering mediastinal fat, and calculated
automatically by the command ‘‘compute volume’’ (Figures 2 and 3). In each
patient, PF was measured by two experienced observers. For accuracy evaluation,
intra-observer and inter-observer intra-class correlations were done for each
image. The inter-observer intra-class correlation was 0.99 (p,0.01). Indexation of
PF by body surface area using the DuBois method was not done due to the high
correlation of the former with absolute PF values (r50.98 p,0.01).
Abdominal visceral fat (AVF) and subcutaneous abdominal fat (SAF) areas
(cm2) were measured by computed tomography (Helical Picker PQ 5000,
Cleveland, OH, USA) at the level of the 4th and 5th (L4 and L5; Figure 4) lumbar
vertebrae. All subjects were examined in the supine position with both arms
stretched above the head, and 10 mm slices were measured at the L4–L5 levels.
Visceral and subcutaneous fat areas (in cm2) were obtained by delineating and
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computing the adipose tissue surface using an attenuation range of 2150 to 250
Hounsfield units.
Statistical Analysis
Data normality was tested by the Kolmogorov-Smirnov test. Normally distributed
data were expressed as mean ¡ standard deviation, while non-normal data were
expressed as median and interquartile ranges. Categorical variables were depicted
as percent frequency (proportions). Chi-square test or Fisher’s exact test were
used to compare categorical variables when pertinent. Continuous variables were
analyzed by Student’s t test or by Mann-Whitney’s test. The correlation between
PF with the other markers of adiposity: waist circumference, BMI, AVF and SAF
was tested by Pearson’s test. Univariate and multivariate logistic regression
analysis were performed to evaluate the association between presence of CAC and
Figure 1. Cross sectional (axial) area of pericardial fat (PF). Colored image outlining axial PF area boundaries. Cardiac silhouette in grey, within PF and
labeled.
doi:10.1371/journal.pone.0114358.g001
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other variables. PF was expressed in standard deviation (SD) units rather than cm3
for better understanding the variability derived by PF range values. Associations
were described through the odds ratios (OR) and 95% confidence intervals (CI).
The direct comparison of CAC presence discrimination by PF and AVF was made
by their individual receiver operating characteristic curves. P values ,0.05 were
considered statistically significant. The analyses were made using, the SPSS
software for Macintosh (IBM SPSS Statistics, Version 20.0. Armonk, NY: IBM
Corp).
Figure 2. Pericardial fat volume, antero-posterior external view of its tridimensional reconstruction.
doi:10.1371/journal.pone.0114358.g002
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Results
Table 1 shows the demographic and clinical characteristics of the studied
population. Patients were predominantly middle-aged men, 25% had diabetes, the
majority had hypertension. Obesity and overweight were found respectively in
27.2% and 59.2% of subjects. According to the CKD classification, 15 patients
(14.6%) were in stage 2, 40 (38.8%) in stage 3, 43 (41.7%) in stage 4, and 5 (4.9%)
in stage 5. Proteinuria was found in 44 (42.7%) of the patients.
The PF was related with age (r50.43, p,0.001) and was higher in men
(220.4¡110.5 vs.135.4¡76.0 cm3 in women, p,0.001). Regarding other
adiposity markers, PF volume correlated with AVF area (r50.82, p,0.01), waist
circumference (r50.67, p,0.01), BMI (r50.57, p,0.01) and SAF area (r50.31,
p,0.01). PF was not related with eGFR (r50.05, p50.65) and was not different in
Figure 3. Pericardial fat (PF) volume, cranio-caudal view of internal and external surface of its tridimensional reconstruction. Exclusion of the most
cranial axial surface to display the internal cavity of PF volume.
doi:10.1371/journal.pone.0114358.g003
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diabetic compared to non-diabetic patients (respectively, 200.4¡110.5 and
186.4¡106.5 cm3, p50.58).
Overall, 61 patients (59.2%) had CAC and among those the median
(interquartile ranges- IQR) calcium score was 219 (IQR 25.5–756.0) AU. Forty-
two patients (40.8%) had no coronary calcification (CAC score 50), in 23
patients (22.4%) CAC score was between 1–100 AU, and in 38 (36.9%) CAC score
was .100 AU. The distribution of PF within CAC50, CAC.0–100 and
CAC.100 groups were respectively, 139.1¡85.0; 221.0¡119.3 and
227.1¡101.5 cm3 (p,0.01).
Table 1 shows the comparison between patients presenting or not CAC. Those
with CAC were older, had a greater prevalence of male gender, and had higher
values of waist circumference (p,0.05). There were no differences between the
groups regarding previous history of hypertension, smoking, diabetes, BMI,
systolic blood pressure values, eGFR as well as laboratory and echocardiographic
parameters. Patients with CAC had higher values of PF volume (p,0.01) and AVF
area (p50.01). However, there was no difference in SAF areas between the two
groups.
Table 2 shows the univariate associations of CAC presence. CAC was positively
related to age, male gender, smoking, waist circumference, PF volumes and AVF
areas. Table 3 shows that PF was independently associated with CAC presence
Figure 4. Cross sectional (axial) area of subcutaneous abdominal fat (SAF) and abdominal visceral fat (AVF) on L4–L5 vertebrae topography. Each
area comprehends contiguous images within outlined boundaries.
doi:10.1371/journal.pone.0114358.g004
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Table 1. Clinical, laboratory and echocardiographic characteristics in the whole study population and according to the presence or not of coronary artery
calcification (CAC).
Variables All CAC50 CAC.0 P value
N (%) 103 (100) 42 (40.8) 61 (59.2)
Age (years) 56.9¡11.0 50.8¡11.2 61.1¡8.6 ,0.001
Gender (male) 64.1% 42.9% 78.7% ,0.001
Diabetes 25.2% 16.7% 31.1% 0.10
Hypertension 95.1% 92.9% 96.7% 0.40
Current Smoker 15.5% 19% 13.1% 0.41
Ever Smoker 51.5% 40.5% 59% 0.07
Body Mass Index (kg/m2) 26.7¡4.9 26.1¡5.6 27.1¡4.3 0.29
Waist Circumference (cm) 93.6¡12.1 90.2¡13.2 95.9¡10.7 0.02
SAP (mmHg) 128¡16 126.8¡16.2 128.7¡16.6 0.55
LVEF (.0.55) 92.2% 97.6% 88.5% 0.14
LVCH 18.4% 11.9% 23% 0.16
Total cholesterol (mg/dl) 184¡37 178¡32 188¡40 0.19
HDL cholesterol (mg/dl) 51¡14 52¡13 51¡15 0.61
LDL cholesterol (mg/dl) 101¡28 97¡26 104¡29 0.18
Triglycerides (mg/dl) 160 (97–208) 121. (99–182) 147 (95–215) 0.63
Creatinine (mg/dL) 2.19¡0.84 2.18¡0.83 2.20¡0.85 0.89
eGFR (ml/min) 36.8¡18.1 37.9¡18.2 36.0¡18.2 0.40
Proteinuria (mg/L) 0.24 (0.00–0.76) 0.2 (0.00–0.76) 0.24 (0.00–0.77) 0.69
Hemoglobin (g/L) 12.8¡1.8 12.8¡1.70 12.8¡1.9 0.98
CRP (mg/dL) 0.27 (0.11–0.70) 0.22 (0.08–0.66) 0.28 (0.15–0.82) 0.15
Phosphorus (mg/dL) 3.8¡0.7 3.67¡0.73 3.81¡0.72 0.32
Ionic Calcium (mmol/L) 1.3¡0.1 1.28¡0.06 1.29¡0.06 0.68
Alkaline Phosphatase (U/L) 80 (66–101) 80 (59.5–104) 81 (68–100) 0.31
iPTH (pg/ml) 103 (62–189) 106 (67.5–197.8) 103 (56.5–160.5) 0.61
PF (cm3) 189.9¡107.2 139.1¡85.0 224.8¡107.6 ,0.01
AVF (cm2) 93.3¡81.4 70.2¡62.9 109.2¡81.5 0.01
SAF (cm2) 179.2¡94.5 180.5¡108.1 178.4¡84.8 0.91
Values displayed in mean ¡ standard deviation or median (percentile 25–percentile 75). SAP-systolic arterial pressure; LVEF-left ventricular ejection
fraction; LVCH-left ventricular concentric hypertrophy; eGFR-estimated glomerular filtration rate; CRP-high sensitivity C reactive protein; iPTH-intact
parathormone; PF-pericardial fat; AVF- abdominal visceral fat; SAF-subcutaneous abdominal fat.
doi:10.1371/journal.pone.0114358.t001
Table 2. Univariate associations with the presence of coronary artery calcification (CAC) by logistic regression analysis.
Variables OR 95% CI p value
Age (years) 1.11 (1.06–1.17) ,0.01
Gender (male) 4.92 (2.07–11.70) ,0.01
Ever Smoking 2.12 (0.95–4.71) 0.07
Pericardial Fat (per SD) 2.85 (1.63–4.98) ,0.01
Abdominal Visceral Fat (per SD) 1.80 (1.13–2.89) 0.01
Waist Circumference (cm) 1.63 (1.06–2.51) 0.03
SD- standard deviation.
doi:10.1371/journal.pone.0114358.t002
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(OR: 1.88 CI: 1.03–3.43) after adjusting for age, gender, diabetes, smoking and,
left ventricular concentric hypertrophy. PF remained associated with CAC even
with additional adjustments for estimated glomerular filtration rate or serum
phosphorus. Figure 5 demonstrates the individual better discriminatory effect of
PF volume versus AVF area for CAC presence (p50.001).
Discussion
This study addressed the association of PF volume with CAC presence measured
by computed tomography in non-dialysis dependent CKD patients. PF was
independently associated with CAC even after adjustment for parameters
previously related with CAC in this population. The results suggest a role of PF, a
component of the visceral fat compartment adjacent to the heart, on the
pathophysiology of coronary vascular calcification development in CKD patients.
Independent Association of PF with CAC
PF is considered as part of the visceral adipose tissue compartment [10], and its
association with CAC could have signaled only a surrogate of the deleterious
effects caused by the more profuse visceral abdominal fat component upon the
coronary arteries. Indeed in this study there was a strong correlation between PF
volume and adipose visceral mass both measured by computed tomography.
Increased abdominal visceral adipose tissue mass has been associated with
subclinical coronary atherosclerosis in subjects with normal kidney function
[11, 23] and with CAC in CKD patients [24]. Abdominal visceral adipocytes
secrete adipocytokines that induce vessel inflammation while at the same time lack
adequate adiponectin secretion, a hormone previous shown to inhibit osteoblast
formation [25]. Indeed these characteristics were also shown for pericardial
adipocytes [26, 27].
Notwithstanding the known endocrine effects of abdominal visceral adipocytes
on the coronary arteries [23], in the present study, PF discriminated CAC
presence better than AVF as was observed by a greater area under the receiver
Table 3. Association of pericardial fat with coronary artery calcification presence after multiple adjustments.
OR 95% CI p value
Model 1
Pericardial Fat (SD) 1.88 1.03–3.43 0.04
Model 2
Pericardial Fat (SD) 1.89 1.05–3.42 0.03
Model 3
Pericardial Fat (SD) 1.85 1.00–3.42 0.05
Model 1: adjusted for age, gender, smoking, diabetes and left ventricular concentric hypertrophy; Model 2: Model 1+ eGFR; Model 3: Model 1+ serum
phosphorus; OR: Odds Ratios; CI: confidence intervals.
doi:10.1371/journal.pone.0114358.t003
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operating curve. This suggests that PF could contribute to CAC development by
both endocrine and paracrine effects [28]. A paracrine effect would mean a direct
contiguous effect where the release of cytokines from pericardial fat could reach
the coronary wall by diffusion, go directly into vasa vasorum or through systemic
circulation [29]. As PF volumes and AVF areas presented an elevated collinearity
it was not adequate to use them concomitantly in any statistical model.
Previous Evidence of the PF and CAC Association in CKD Patients
In CKD patients Turkmen et al. found a positive association of epicardial fat, a
subset of PF located below the visceral pericardial sac, with CAC presence in
peritoneal dialysis patients [16]. In that study epicardial fat was associated with
CAC independently of BMI. D9Marco et al. found in a post hoc subgroup analysis
of the Renagel in New Dialysis (RIND) study a positive association between
epicardial fat and overall mortality in incident hemodialysis patients [30].
Figure 5. Receiving operating characteristic curves (ROC) for pericaridal fat (PF) volumes and abdominal visceral fat (AVF) for coronary artery
calcification (CAC) presence.
doi:10.1371/journal.pone.0114358.g005
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In non-end stage CKD patients only one study had addressed the relation of CAC,
laboratory biomarkers, diabetes, and renal function with epicardial fat measured
by computed tomography [17]. Kerr et al. evaluated 94 pre-dialysis stage 3–5
CKD patients, mean age: 63.7 years, 56% male, and mean eGFR of
25.1¡11.9 mL/min/1.73 m2. In that study CAC and serum levels of interleukin-6
were associated with epicardial fat volume (the dependent variable). The current
study addresses this association by two different aspects: first, PF that comprises
not only epicardial fat, that is located directly over the coronary arteries, but also
within the rest of the pericardial sac was measured; second, we depart from PF to
CAC (the dependent variable) as the physiopathological premise is PF being a
promoter of CAC rather than the opposite.
Clinical Implications and Further Research
The results of this study reinforce the possible role of ectopic fat accumulation on
the rather complex pathophysiology of CAC in CKD patients [8, 9]. It is likely that
PF contributes to CAC independently of abdominal fat and its determination by
computed tomography might have clinical implications since CAC is an
independent marker of cardiovascular morbidity and mortality in the CKD
population [4–7]. However, larger and prospective studies are necessary to prove
this point. Also, it would be necessary to show that if reduction of PF could alter
the course of cardiovascular disease in this population.
Study Limitations
This is a post-hoc analysis of a cohort of CKD patients. However, all the data
including clinical, laboratory and computed tomography parameters were
collected concomitantly. So far there is no gold standard in the literature to
adequately quantify the different components of thoracic ectopic adipose tissue
that comprises pericardial, epicardial and intra-thoracic components. Therefore,
the comparison of this study with previous results should be made with care.
However, it is important to reinforce the high reliability of our measurement
technique, confirmed by the high inter-observer index.
On the multivariate analysis the confounding effect of hypertension for CAC is
paramount. As more than 95% of the sample was hypertensive, using simply
categorical labeling would not identify all the differential spectrum of exposition
burden. Systolic arterial pressure as well would not discriminate this hemody-
namic burden, since the sample had a good average control due to
antihypertensive medication. So, concentric hypertrophy was used as marker of
hypertension burden in our population. Indeed Ertu¨k [31] et al. found a good
association of echocardiographic ventricular hypertrophy with systolic burden by
ambulatory arterial blood pressure monitoring in a CKD dialysis sample. Also
Ehara et al. [32] demonstrated that the absence of concentric hypertrophy was
associated with CAC absence in a non-CKD population referred for suspected
coronary artery disease. These data support the usage of concentric hypertrophy
Pericardial Fat and Coronary Calcification in CKD
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as a confounder for the studied association. Finally, the nature of this study only
allows showing association and not causality.
Conclusion
PF volume measured by computed tomography was associated with CAC
presence in non-dialysis dependent CKD population. Further studies are required
to evaluate this association.
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